Japan eases many Covid-era border restrictions as cases slump

The easing also means government will begin reissuing visas for long and short-term stays, which will mainly affect foreign students, technical trainee workers and those relocating to Japan for work

Japan, Covid-19, coronavirus,
Photo: Bloomberg
Lisa Du | Bloomberg
2 min read Last Updated : Nov 05 2021 | 4:58 PM IST
Japan announced a broad easing of Covid-era border control measures that will relax restrictions for visitors such as students and those traveling for business, seeking to reopen the economy after a dramatic drop in virus cases and a vaccination campaign that’s inoculated more than 70% of the population.

The changes, which take effect Monday, would shorten quarantine from 10 to 3 days for short-term business travelers and Japanese nationals or foreign residents returning from abroad if they have received a vaccine approved in Japan, according to a Friday announcement from the Ministry of Foreign Affairs. The Nikkei reported the news earlier this week. 

The easing also means the government will begin reissuing visas for long and short-term stays, which will mainly affect foreign students, technical trainee workers and those relocating to Japan for work. Tourists are still not allowed in the country.

The loosening of restrictions comes as the number of coronavirus cases have plummeted to a few hundred per day nationally, and after Japan’s ruling party maintained its majority in Sunday’s national election. The island nation had enacted one of the strictest border policies among developed nations during the pandemic, effectively banning most foreigners from entering unless they already held a visa.

The latest easing won’t fully apply to a small list of countries Japan still deems high-risk, and those who’ve received vaccines other than those approved by Japan -- shots from Pfizer Inc. and BioNTech SE, Moderna Inc. or AstraZeneca Plc. -- also won’t qualify.

Much of the Covid border restrictions have affected students and technical workers trying to enter Japan. In recent months, business lobbies and foreign chambers of commerces had begun calling for the government to ease restrictions.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusJapanCoronavirus Vaccine

Next Story